Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rimonabant

Tablet, oral administration

DRUG

Placebo (for Rimonabant)

Tablet, oral administration

DRUG

Metformin

Metformin continued at stable dose as background therapy

Trial Locations (13)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Jakarta

Sanofi-Aventis Administrative Office, Vilnius

Sanofi-Aventis Administrative Office, Kuala Lumpur

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Makati City

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Brastislava

Sanofi-Aventis Administrative Office, Taipei

Sanofi-Aventis Administrative Office, Bangkok

Sanofi-Aventis Administrative Office, Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY